美国医疗保险和医疗补助服务中心医院消费者对医疗保健提供者和系统的评估(HCAHPS)评分与妇科肿瘤手术结局
这项观察性研究利用2009至2011年HCAHPS调查数据将美国651所医院按评分三分位分组,并链接全国住院患者样本中17509例妇科癌症手术住院记录。结果发现,HCAHPS评分最高三分位医院相比最低三分位医院,院内死亡率更低(OR 0.54,95%CI 0.31-0.94),手术并发症更少(OR 0.82,95%CI 0.69-0.98),而医疗并发症、护理团队相关并发症、总体并发症及住院时间延长与HCAHPS评分无显著关联(p>0.05)。
要点
- HCAHPS评分最高三分位医院院内死亡率低于最低三分位医院(OR 0.54,95%CI 0.31-0.94)。
- HCAHPS评分较高医院的手术并发症更少(OR 0.82,95%CI 0.69-0.98)。
- 医疗并发症、护理团队并发症、总体并发症及住院时间延长与HCAHPS评分无显著关联(p>0.05)。
核心结论
- 在HCAHPS评分最高三分位医院进行的妇科肿瘤手术,相比最低三分位医院,与更低的院内死亡率和更少的手术并发症相关。
- HCAHPS评分与其他不良事件之间未见关联。
研究设计与样本
- 观察性研究,使用2009至2011年HCAHPS调查数据将医院按评分分为三分位。
- 利用全国住院患者样本(NIS)数据库识别同期妇科癌症特异性手术住院记录,数据在医院层面链接。
- 共纳入美国651所医院的17509例链接住院记录,其中51%为子宫癌、40%为卵巢癌、9%为宫颈癌手术住院。
- 采用混合效应模型,调整患者和医院层面变量后评估HCAHPS评分与结局的关联。
主要发现
- HCAHPS评分最高三分位医院相比最低三分位医院,院内死亡率更低(OR 0.54,95%CI 0.31-0.94)。
- HCAHPS评分较高医院的手术并发症更少(OR 0.82,95%CI 0.69-0.98)。
- 医疗并发症、护理团队并发症、总体并发症及住院时间延长与HCAHPS评分无显著关联(p>0.05)。
关键数值与推荐
- 院内死亡率:最高三分位 vs 最低三分位,OR 0.54(95%CI 0.31-0.94)。
- 手术并发症:较高评分医院 vs 较低评分医院,OR 0.82(95%CI 0.69-0.98)。
- 医疗并发症、护理团队并发症、总体并发症及住院时间延长与HCAHPS评分无显著关联(p>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) is a national survey of inpatient experience. This study evaluated the association between HCAHPS survey results and outcomes in gynecologic cancer surgery. METHODS: This observational study used HCAHPS survey data from 2009 to 2011 to assign hospitals into score terciles. The Nationwide Inpatient Sample (NIS) database was used to identify admissions during the same time period for gynecologic cancer-specific surgeries. Data sources were linked at the hospital level. Postoperative complications, mortality, and prolonged length of stay were compared between higher and lower scoring hospitals. Complications were grouped as 'surgical', 'medical', or 'care team'. Mixed effects models were used to evaluate the associations between hospitals' HCAHPS scores and outcomes after adjustment for patient and hospital-level variables. RESULTS: 17,509 linked encounters in 651 hospitals across the U.S. were identified, with 51% uterine, 40% ovarian, and 9% cervical cancer surgical admissions. In-hospital mortality was lower in hospitals in the top HCAHPS score terciles compared to bottom HCAHPS score tercile (odds ratio (OR) 0.54, 95% CI: 0.31-0.94). Surgery in higher scoring HCAHPS hospitals was associated with less 'surgical' complications (OR 0.82, 95% CI 0.69-0.98). No association was found between 'medical', 'care team', overall complications, or prolonged hospitalization (p > 0.05) and HCAHPS scores. CONCLUSIONS: Gynecologic oncology surgeries performed in top HCAHPS tercile hospitals were associated with lower in-hospital mortality and surgical complications compared to surgeries performed in bottom tercile hospitals. Associations between HCAHPS scores and other adverse events were not seen.
引用
- Dottino JA, He W, Sun CC, et al. Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes. Gynecol Oncol. 2019. PMID: 31208738. doi:10.1016/j.ygyno.2019.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。